Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

A diaCEST MRI approach for monitoring liposomal accumulation in tumors.

Chan KW, Yu T, Qiao Y, Liu Q, Yang M, Patel H, Liu G, Kinzler KW, Vogelstein B, Bulte JW, van Zijl PC, Hanes J, Zhou S, McMahon MT.

J Control Release. 2014 Apr 28;180:51-9. doi: 10.1016/j.jconrel.2014.02.005. Epub 2014 Feb 15.

2.

Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI).

Yu T, Chan KW, Anonuevo A, Song X, Schuster BS, Chattopadhyay S, Xu Q, Oskolkov N, Patel H, Ensign LM, van Zjil PC, McMahon MT, Hanes J.

Nanomedicine. 2015 Feb;11(2):401-5. doi: 10.1016/j.nano.2014.09.019. Epub 2014 Nov 15.

3.

Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications.

Chan KW, Bulte JW, McMahon MT.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Jan-Feb;6(1):111-24. doi: 10.1002/wnan.1246. Epub 2013 Oct 8. Review.

4.

Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma.

Grange C, Geninatti-Crich S, Esposito G, Alberti D, Tei L, Bussolati B, Aime S, Camussi G.

Cancer Res. 2010 Mar 15;70(6):2180-90. doi: 10.1158/0008-5472.CAN-09-2821. Epub 2010 Mar 9.

5.

Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes.

Paoli EE, Ingham ES, Zhang H, Mahakian LM, Fite BZ, Gagnon MK, Tam S, Kheirolomoom A, Cardiff RD, Ferrara KW.

J Control Release. 2014 Mar 28;178:108-17. doi: 10.1016/j.jconrel.2014.01.005. Epub 2014 Jan 13.

6.

Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.

Kato Y, Zhu W, Backer MV, Neoh CC, Hapuarachchige S, Sarkar SK, Backer JM, Artemov D.

Pharm Res. 2015 Nov;32(11):3746-55. doi: 10.1007/s11095-015-1736-9. Epub 2015 Jun 16.

PMID:
26078000
7.

Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein.

Wang T, Hartner WC, Gillespie JW, Praveen KP, Yang S, Mei LA, Petrenko VA, Torchilin VP.

Nanomedicine. 2014 Feb;10(2):421-30. doi: 10.1016/j.nano.2013.08.009. Epub 2013 Sep 9.

8.

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.

Gabizon A, Tzemach D, Gorin J, Mak L, Amitay Y, Shmeeda H, Zalipsky S.

Cancer Chemother Pharmacol. 2010 May;66(1):43-52. doi: 10.1007/s00280-009-1132-4. Epub 2009 Sep 25.

PMID:
19779718
9.
10.

Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.

Shahin M, Soudy R, El-Sikhry H, Seubert JM, Kaur K, Lavasanifar A.

Cancer Lett. 2013 Jul 1;334(2):284-92. doi: 10.1016/j.canlet.2012.10.007. Epub 2012 Oct 13.

PMID:
23073474
11.

Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models.

Gabizon A, Tzemach D, Mak L, Bronstein M, Horowitz AT.

J Drug Target. 2002 Nov;10(7):539-48.

PMID:
12683721
12.
13.

Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging.

Saito R, Bringas JR, McKnight TR, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS.

Cancer Res. 2004 Apr 1;64(7):2572-9.

14.

Magnetic resonance guided high-intensity focused ultrasound mediated hyperthermia improves the intratumoral distribution of temperature-sensitive liposomal doxorubicin.

de Smet M, Hijnen NM, Langereis S, Elevelt A, Heijman E, Dubois L, Lambin P, Grüll H.

Invest Radiol. 2013 Jun;48(6):395-405. doi: 10.1097/RLI.0b013e3182806940.

PMID:
23399809
15.

Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study.

de Smet M, Heijman E, Langereis S, Hijnen NM, Grüll H.

J Control Release. 2011 Feb 28;150(1):102-10. doi: 10.1016/j.jconrel.2010.10.036. Epub 2010 Nov 6.

PMID:
21059375
16.

Radiolabeled liposome imaging determines an indication for liposomal anticancer agent in ovarian cancer mouse xenograft models.

Ito K, Hamamichi S, Asano M, Hori Y, Matsui J, Iwata M, Funahashi Y, Umeda IO, Fujii H.

Cancer Sci. 2016 Jan;107(1):60-7. doi: 10.1111/cas.12841. Epub 2015 Nov 30.

17.

Sonosensitive theranostic liposomes for preclinical in vivo MRI-guided visualization of doxorubicin release stimulated by pulsed low intensity non-focused ultrasound.

Rizzitelli S, Giustetto P, Cutrin JC, Delli Castelli D, Boffa C, Ruzza M, Menchise V, Molinari F, Aime S, Terreno E.

J Control Release. 2015 Mar 28;202:21-30. doi: 10.1016/j.jconrel.2015.01.028. Epub 2015 Jan 24.

PMID:
25626083
18.
19.

Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats.

Ten Hagen TL, Van Der Veen AH, Nooijen PT, Van Tiel ST, Seynhaeve AL, Eggermont AM.

Int J Cancer. 2000 Sep 15;87(6):829-37.

20.

Local targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin.

Zhao C, Feng Q, Dou Z, Yuan W, Sui C, Zhang X, Xia G, Sun H, Ma J.

PLoS One. 2013 Sep 11;8(9):e73860. doi: 10.1371/journal.pone.0073860. eCollection 2013.

Items per page

Supplemental Content

Write to the Help Desk